Efficacy of rociletinib (co-1686) in EGFR-mutant non-small cell lung cancer (NSCLC) patients (pts) assessed with a plasma EGFR test Meeting Abstract


Authors: Gadgeel, S.; Soria, J. C.; Goldman, J. W.; Wakelee, H.; Camidge, D. R.; Yu, H.; Varga, A.; Solomon, B.; Oxnard, G. R.; Ou, S. H.; Papadimitrakopoulou, V.; Liu, S. V.; Reckamp, K.; Spira, A.; Piotrowska, Z.; Despain, D.; Karlovich, C.; Yurasov, S.; Sequist, L. V.
Abstract Title: Efficacy of rociletinib (co-1686) in EGFR-mutant non-small cell lung cancer (NSCLC) patients (pts) assessed with a plasma EGFR test
Meeting Title: 18th European Cancer Conference (ECCO 18)
Journal Title: European Journal of Cancer
Volume: 51
Issue: Suppl. 3
Meeting Dates: 2015 Sep 25-29
Meeting Location: Vienna, Austria
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2015-09-01
Start Page: S628
Language: English
ACCESSION: WOS:000361887403046
PROVIDER: wos
DOI: 10.1016/S0959-8049(16)31729-4
Notes: Meeting Abstract: 3088 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Helena Alexandra Yu
    281 Yu